Aimei Health is no longer a healthcare-search story. It is a high-risk de-SPAC watch where a small remaining SPAC trust is trying to close a $1.5 billion all-share United Hydrogen transaction.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
